Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Evotec Reports $25M Payment From Bristol Myers Squibb For Achievements In Strategic Neuroscience Partnership Focused On Disease-Modifying Therapies

Author: Benzinga Newsdesk | October 27, 2025 02:06am

Advances made in preclinical pipeline addressing neurodegenerative diseases
Evotec receives US$ 25 m payment to support continued progression of joint programs

Posted In: BMY EVO